_JIKK_2024-2.pdf_.png)
1.png){kind=logo}
.png)
.png)
.png)
.jpg)
Heparin Vs Enoxaparin: Effects On D-Dimer And Hospital Stay In Covid-19 Patients
Sari
Elevated d-dimer levels due to venous thromboembolism and hypercoagulability in covid-19 patients play a role in disease severity and poor clinical outcomes. This study aims to compare the effectiveness of heparin and enoxaparin, two recommended anticoagulants, in reducing d-dimer levels and hospital stay duration in hospitalized covid-19 patients. This retrospective cohort study involved 106 hospitalized covid-19 patients with abnormal d-dimer levels treated between March 2020 and March 2023. The assessment included changes in d-dimer levels and hospitalization duration. Statistical analyses were performed using stata software. Patients receiving enoxaparin were 5.913 times more likely to experience a reduction in d-dimer levels compared to those receiving heparin (p=0.021). While smoking status (or=0.034; p=0.001) and the number of comorbidities (or=11.247; p=0.018) were notable factors influencing d-dimer reduction, enoxaparin administration was linked to significantly longer hospitalization (p=0.024). The severity of covid-19 also had a substantial impact on hospital stays, with severe (β = 5.757; p= 0.004) and critical (β = 9.147; p <0.001) cases requiring extended care. Thus, enoxaparin demonstrates greater efficacy in reducing d-dimer levels in hospitalized covid-19 patients, though at the cost of prolonged hospital stays.
Kata Kunci
Teks Lengkap:
PDFReferensi
Al-Dahy, L. B., & Abed, F. A. (2022). Effect of Smoking on D-dimer Level at COVID-19 Patients. Indian Journal of Forensic Medicine & Toxicology, 16(4), 299-302. doi: 10.37506/ijfmt.v16i4.19218.
Al Sulaiman, K., Aljuhani, O., Korayem, G. B., Hafiz, A., Alalawi, M., Badreldin, H. A., et al. (2022). Standard dosing of enoxaparin versus unfractionated heparin in critically ill patient with COVID-19: a multicenter propensity-score matched study. Thrombosis Journal, 20(1), 74. doi: 10.1186/s12959-022-00391-7.
Cascella, M., Rajnik, M., Aleem, A., Dulebohn, S.C., & Di Napoli, R. (2025). Features, evaluation, and treatment of coronavirus (COVID-19). Treasure Island (FL): StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK554776/
Chaiut, W., Sapbamrer, R., Dacha, S., Sudjaritruk, T., Parwati, I., Sumarpo, A. and Malasao, R. (2023). Characteristics of respiratory syncytial virus infection in hospitalized children before and during the COVID-19 pandemic in Thailand, Journal of Preventive Medicine and Public Health, 56(3), 212.
Djaharuddin, I., Munawwarah, S., Nurulita, A., Ilyas, M., Tabri, N. A., & Lihawa, N. (2021). Comorbidities and mortality in COVID-19 patients. Gaceta sanitaria, 35, S530-S532. doi: 10.1016/j.gaceta.2021.10.005.
Erben, Y., Franco-Mesa, C., Gloviczki, P., Stone, W., Quinones-Hinojoas, A., Meltzer, A. J., et al. (2021). Deep vein thrombosis and pulmonary embolism among hospitalized coronavirus disease 2019–positive patients predicted for higher mortality and prolonged intensive care unit and hospital stays in a multisite healthcare system. Journal of Vascular Surgery: Venous and Lymphatic Disorders, 9(6), 1361-1370. doi: 10.1016/j.jvsv.2021.04.001.
Imbalzano, E., Orlando, L., Dattilo, G., Gigliotti De Fazio, M., Camporese, G., Russo, V., et al. (2024). Update on the Pharmacological Actions of Enoxaparin in Nonsurgical Patients. Medicina, 60(1), 156. doi: 10.3390/medicina60010156.
Indonesia Ministry of Health. (2020). Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/MENKES/413/2020 Tentang Pedoman Pencegahan dan Pengendalian Coronavirus Disease 2019 (COVID-19).
https://peraturan.bpk.go.id/Download/164813/Kepmenkes%20HK.01.07-Menkes-413-2020.pdf
Khajuria, A., Bobdey, S., Kumar, S., Sahu, R., Vashisht, R., Bhaskar, V., et al. (2021). An analysis of length of hospital stay of COVID-19 patients admitted in a dedicated COVID-19 hospital. Journal of Marine Medical Society, 23(2), 145-148.
Lee, A. J., Fowkes, F. G. R., Lowe, G. D., & Rumley, A. (1995). Determinants of fibrin D-dimer in the Edinburgh Artery Study. Arteriosclerosis, thrombosis, and vascular biology, 15(8), 1094-1097.
Malas, M. B., Naazie, I. N., Elsayed, N., Mathlouthi, A., Marmor, R., & Clary, B. (2020). Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: a systematic review and meta-analysis. EClinicalMedicine, 29:100639. doi: 10.1016/j.eclinm.2020.100639.
Nopp, S., Moik, F., Jilma, B., Pabinger, I., & Ay, C. (2020). Risk of venous thromboembolism in patients with COVID‐19: a systematic review and meta‐analysis. Research and practice in thrombosis and haemostasis, 4(7), 1178-1191. doi: 10.1002/rth2.12439.
Oliynyk, O., Barg, W., Slifirczyk, A., Oliynyk, Y., Dubrov, S., Gurianov, V., & Rorat, M. (2021). Comparison of the effect of unfractionated heparin and enoxaparin sodium at different doses on the course of COVID-19-associated coagulopathy. Life, 11(10), 1032. doi: 10.3390/life11101028.
Padayachee, N., Schoeman, N., & Schellack, N. (2021). Enoxaparin. SA Pharmaceutical Journal, 88(2), 26-29.
Pawlowski, C., Venkatakrishnan, A. J., Kirkup, C., Berner, G., Puranik, A., O'Horo, J. C., et al. (2021). Enoxaparin is associated with lower rates of mortality than unfractionated Heparin in hospitalized COVID-19 patients. EClinicalMedicine, 33: 100774. doi: 10.1016/j.eclinm.2021.100771.
Raharjo, B., Kurniawati, R., Wijayanti, C.D.W., Linggawan, S., Sumarpo, A. and Bintoro, S.U.Y. (2025). Hubungan rasio monosit/high density lipoprotein (HDL) dengan indeks massa tubuh pada pasien dengan penyakit jantung coroner. Holistik Jurnal Kesehatan, 19(2), 349-354
Rees, E. M., Nightingale, E. S., Jafari, Y., Waterlow, N. R., Clifford, S., B. Pearson, C. A., et al. (2020). COVID-19 length of hospital stay: a systematic review and data synthesis. BMC medicine, 18(1), 270. doi: 10.1186/s12916-020-01726-3.
Samuel, S., Li, W., Dunn, K., Cortes, J., Nguyen, T., Moussa, D., et al. (2023). Unfractionated heparin versus enoxaparin for venous thromboembolism prophylaxis in intensive care units: a propensity score adjusted analysis. Journal of Thrombosis and Thrombolysis, 55(4), 617-625. doi: 10.1007/s11239-023-02683-5.
Sumarpo, A., Fenny, F. and Suraya, N. (2025). Kajian pustaka: hipertensi renovaskuler. Jurnal Ilmu Kedokteran Dan Kesehatan, 12(1).
Thai, P. Q., Son, D. T., Van, H. T. H., Minh, L. N., Hung, L. X., Van Toan, N., et al. (2020). Factors associated with the duration of hospitalisation among COVID-19 patients in Vietnam: A survival analysis. Epidemiology & Infection, 148, e114. doi: 10.1017/S0950268820001263.
Zang, L., Zhu, H., Wang, K., Liu, Y., Yu, F., & Zhao, W. (2022). Not just anticoagulation—new and old applications of heparin. Molecules, 27(20), 6968. doi: 10.3390/molecules27206968.
Zhan, H., Chen, H., Liu, C., Cheng, L., Yan, S., Li, H., & Li, Y. (2021). Diagnostic value of D-dimer in COVID-19: a meta-analysis and meta-regression. Clinical and Applied Thrombosis/Hemostasis, 27, 10760296211010976. doi: 10.1177/10760296211010976.
Zhang, L., Yan, X., Fan, Q., Liu, H., Liu, X., Liu, Z., & Zhang, Z. (2020). D‐dimer levels on admission to predict in‐hospital mortality in patients with Covid‐19. Journal of thrombosis and haemostasis, 18(6), 1324-1329. doi: 10.1111/jth.14859.
DOI: https://doi.org/10.33024/jikk.v13i3.23094
Refbacks
- Saat ini tidak ada refbacks.
##submission.copyrightStatement##
##submission.license.cc.by-nc4.footer##
Pendidikan Dokter Universitas Malahayati Lampung
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.